Compugen (CGEN) Depreciation & Amortization (CF) (2009 - 2010)

Compugen's (CGEN) quarterly Depreciation & Amortization (CF) came in at $50000.0 in Q4 2010, up 316.67% year-on-year from $12000.0 in Q4 2009, and down 1.96% quarter-over-quarter from $51000.0 in Q3 2010.

Compugen (CGEN) Depreciation & Amortization (CF) (2009 - 2010) Analysis & Trends

Compugen has disclosed Depreciation & Amortization (CF) across 2 years of filings, most recently posting $50000.0 for Q4 2010.

  • Depreciation & Amortization (CF) for Q4 2010 came in at $50000.0, up 316.67% year-over-year; the trailing twelve-month figure through Sep 2011 was $50000.0 (down 20.63% YoY), and the FY2025 annual result was $475000.0, down 2.26% from the prior year.
  • Depreciation & Amortization (CF) came in at $50000.0 for Q4 2010 at Compugen, down from $51000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $51000.0 in Q3 2010 to a low of $12000.0 in Q4 2009.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2010 50,000.00
Dec 31, 2010 50,000.00
Sep 30, 2010 51,000.00
Sep 30, 2010 51,000.00
Dec 31, 2009 12,000.00
Dec 31, 2009 12,000.00
Sep 30, 2009 48,000.00
Sep 30, 2009 48,000.00